Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

All their link evidence assumes reactionary regulation, not liability regulations

Maliha, 21

[George, MD, is a second-year internal medicine resident at the University of Pennsylvania Health System, 7-13-2021, “To Spur Growth in AI, We Need a New Approach to Legal Liability”, Harvard Business Review, , accessed 7-18-2022, BB]

Granted, a regulatory scheme that attempts to specify an AI system completely will almost certainly hamper innovation. But those costs may be acceptable in particular areas such as drug development, where comprehensive Food and Drug Administration regulatory schemes can replace liability completely.

Given the tremendous innovation engendered by AI, it is often easy to ignore liability concerns until the offering makes it to market. Policymakers, designers, and end users of AI should develop a balanced liability system to facilitate AI — rather than merely react to it. Building this 21st century liability system will ensure that 21st century AI will flourish.

Sign in to recut, update, or save this card.